State Pharmaceutical & Medical Supply Corporation Ltd (StatePharma) has entered into strategic talks with European pharmaceutical giant AstraZeneca to strengthen the security and continuity of high-quality medicine supply chains across the Maldives.
The bilateral consultation, focused on establishing a long-term commercial partnership and addressing healthcare supply dynamics, was led by StatePharma Managing Director Dr. Shah Mahir and AstraZeneca Country Business Manager Abhishek Kaushik.
Key Objectives and Commercial Framework
The collaboration centers on expanding access to specialized pharmaceuticals while modernizing the state-led healthcare logistics network. Primary focus areas discussed include:
- Strategic Supply Chain Continuity: Securing direct distribution pipelines for essential medicines to prevent regional shortages
- Long-Term Procurement Alignment: Establishing direct manufacturer partnerships to improve quality control and cost efficiencies
- Healthcare Infrastructure Integration: Aligning pharmaceutical delivery with broader national healthcare development initiatives
AstraZeneca, a global biopharmaceutical leader operating in over 125 countries, represents a major international